Mesenchymal Stem Cells for The Treatment of Acute Ischemic Stroke

PHASE1RecruitingINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

December 5, 2019

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2025

Conditions
Acute Ischemic Stroke
Interventions
BIOLOGICAL

UMC119-06

Cohort 1: Low does of UMC119-06;Cohort 2: Medium does of UMC119- 06;Cohort 3: High does of UMC119-06

Trial Locations (1)

23561

RECRUITING

Taipei Medical University - Shuang Ho Hospital, Ministry of Health and Welfare., New Taipei City

Sponsors
All Listed Sponsors
lead

Meridigen Biotech Co., Ltd.

INDUSTRY

NCT04097652 - Mesenchymal Stem Cells for The Treatment of Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter